PCVX

Q: What is the price of Vaxcyte (PCVX) today?

The price of Vaxcyte (PCVX) today is $ 44.50, with return of -49.27% compared to the last year. The price of Vaxcyte (PCVX) started the year trading around $ 81.86 and today it is at $ 44.50. Follow the real-time price chart, the historical price of Vaxcyte (PCVX) and international markets.

Q: When does Vaxcyte (PCVX) pay dividends?

Vaxcyte (PCVX) did not distribute dividends in the last year.

Q: Is Vaxcyte (PCVX) worth it?

Currently, Vaxcyte (PCVX) is priced at $ 44.50, with a P/E of -9.62%, representing a deviation of -1,747% from its historical average P/E. In the last year, the stock showed a variation of -49.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -49.27%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Vaxcyte (PCVX) stock?

Investing in stocks of Vaxcyte (PCVX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Vaxcyte (PCVX) yield today?

The yield of Vaxcyte (PCVX) was -2.31% in the last month, -49.27% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Vaxcyte (PCVX) today, the total investment would be $ 4,450.00, based on the current price of $ 44.50.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,257.49In 5 years: $ 4,450.00In 10 years: $ 4,450.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Vaxcyte Inc.

Price

$ 44.50

return (12m)

-49.27%

p/e

-9.62

p/bv

2.19

DIVIDEND YIELD

0.00%

price PCVX

PCVX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of PCVX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.31%

3 months

38.33%

1 year

-49.27%

2 years

-26.56%

5 years

0.00%

10 years

0.00%

Fundamentals PCVX

review the fundamentals of Vaxcyte shares

P/E

-9.62

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

Sector: -3.71 Industry: -3.71

P/BV

2.19

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-20.72%

Sector: -63.91% Industry: -63.91%

ROE

-22.72%

Sector: -67.36% Industry: -67.36%

ROIC

-63.92%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

0.00%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

0.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

0.00%

Sector: -41.51% Industry: -41.51%

P/EBITDA

-9.20

Sector: -3.78 Industry: -3.78

P/EBIT

-8.94

Sector: -3.91 Industry: -3.91

P/ASSET

1.99

Sector: 1.49 Industry: 1.49

BVPS

21.27

Sector: 1.73 Industry: 1.73

EPS

-4.83

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.91

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

49.09%

Sector: - Industry: -

Fundamentals PCVX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.36	0.00	0.00%	2.52%	$ 486.25 B	27.26%
PFE	15.06	1.59	10.56%	6.61%	$ 147.98 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.76	6.09	20.45%	1.74%	$ 279.74 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.58	7.02	37.80%	2.59%	$ 150.68 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.44	14.70	118.17%	0.00%	$ 7.41 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	25.34	18.45	72.82%	2.85%	$ 177.48 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.65	11.00	48.57%	0.00%	$ 4.74 B	42.87%
BIIB	16.57	1.46	8.83%	0.00%	$ 26.65 B	15.98%
HRMY	12.44	2.77	22.24%	0.00%	$ 2.31 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

PCVX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Vaxcyte

Vaxcyte Inc.

Average user rating I10

4.0 (0 people)

United States

12 years

Founded: 2013

2020

Time since IPO - 5 years

58

Employees

The Company Vaxcyte Inc. (United States), is listed on Nasdaq with a market value of $ 6.32 Billions, having an equity of $ 2.89 Billions.

With a total of 58 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -657.20 Millions.

As for its main indicators, the Company has a P/E ratio of -9.62, a P/BV ratio of 2.19 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker PCVX.

Market cap

$ 6.32 Billions

Net worth

$ 2.89 Billions

US$ 2,892,880,000.00

Assets

$ 3.17 Billions

US$ 3,171,600,000.00

Total Shares Outstanding

136.00 Millions

136,000,000

Average Daily Trading Volume

$ 1.64 Million

US$ 1,640,774.32

Sector

Health Care

Industry

Biotechnology

PCVX

PCVX revenue and profits

Financial Results PCVX

DRAG THE FRAME TO SEE MORE DATA

PCVX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

19.36

2.52%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

15.06

6.61%

ROE

10.56%

P/BV

1.59

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.76

1.74%

ROE

20.45%

P/BV

6.09

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

19.36

2.52%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

15.06

6.61%

ROE

10.56%

P/VP

1.59

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.76

1.74%

ROE

20.45%

P/VP

6.09

Frequently Asked Questions

What is the price of Vaxcyte (PCVX) today?

The price of Vaxcyte (PCVX) today is $ 44.50, with return of -49.27% compared to the last year. The price of Vaxcyte (PCVX) started the year trading around $ 81.86 and today it is at $ 44.50. Follow the real-time price chart, the historical price of Vaxcyte (PCVX) and international markets.

When does Vaxcyte (PCVX) pay dividends?

Vaxcyte (PCVX) did not distribute dividends in the last year.

Is Vaxcyte (PCVX) worth it?

Currently, Vaxcyte (PCVX) is priced at $ 44.50, with a P/E of -9.62%, representing a deviation of -1,747% from its historical average P/E. In the last year, the stock showed a variation of -49.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -49.27%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Vaxcyte (PCVX) stock?

Investing in stocks of Vaxcyte (PCVX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Vaxcyte (PCVX) yield today?

The yield of Vaxcyte (PCVX) was -2.31% in the last month, -49.27% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Vaxcyte (PCVX) today, the total investment would be $ 4,450.00, based on the current price of $ 44.50.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2,257.49
In 5 years: $ 4,450.00
In 10 years: $ 4,450.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

PCVX

Vaxcyte Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of PCVX

review the fundamentals of Vaxcyte shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Vaxcyte

Vaxcyte Inc.

United States

12 years

2020

58

PROFIT X PRICE PCVX

Financial Results PCVX

PCVX cash flow

asset growth - PCVX

PCVX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions